AQUATAG Drug Patent Profile
✉ Email this page to a colleague
When do Aquatag patents expire, and when can generic versions of Aquatag launch?
Aquatag is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in AQUATAG is benzthiazide. There is one drug master file entry for this compound. Additional details are available on the benzthiazide profile page.
Summary for AQUATAG
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Patent Applications: | 3,705 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AQUATAG at DailyMed |
US Patents and Regulatory Information for AQUATAG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solvay | AQUATAG | benzthiazide | TABLET;ORAL | 016001-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Solvay | AQUATAG | benzthiazide | TABLET;ORAL | 016001-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |